NCT03194542 2023-08-24A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion DependenceCelgenePhase 2 Completed95 enrolled 32 charts